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Purpose: Leksell Gamma Knife R© is a stereotactic radiosurgery system that allows
fine-grained control of the delivered dose distribution. We describe a new inverse
planning approach that both resolves shortcomings of earlier approaches and unlocks
new capabilities.
Methods: We fix the isocenter positions and perform sector-duration optimization
using linear programming, and study the effect of beam-on time penalization on the
trade-off between beam-on time and plan quality. We also describe two techniques
that reduce the problem size and thus further reduce the solution time: dualization
and representative subsampling.
Results: The beam-on time penalization reduces the beam-on time by a factor 2–
3 compared with the na¨ıve alternative. Dualization and representative subsampling
each leads to optimization time-savings by a factor 5–20. Overall, we find in a
comparison with 75 clinical plans that we can always find plans with similar coverage
and better selectivity and beam-on time. In 44 of these, we can even find a plan
that also has better gradient index. On a standard GammaPlan workstation, the
optimization times ranged from 2.3 to 26 s with a median time of 5.7 s.
Conclusion: We present a combination of techniques that enables sector-duration
optimization in a clinically feasible time frame.
Keywords: Stereotactic radiosurgery, Leksell Gamma Knife R©, treatment planning,
inverse planning, optimization
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I. INTRODUCTION
Stereotactic radiosurgery (SRS) is defined as the use of externally generated ionizing ra-
diation to inactivate or eradicate defined targets, typically in the head or spine, without
the need for a surgical incision1. Present-day neurosurgeons routinely use stereotactic radio-
surgery for the management of a wide variety of brain disorders, including certain malignant
and benign tumors2–5, as well as cardiovascular and functional disorders within the brain6–9.
Leksell Gamma Knife R© (LGK) is a dedicated system for intracranial stereotactic radio-
surgery. Its most recent incarnations, PerfexionTMand IconTM, use 192 60Co sources, each
emitting gamma radiation. The radiation is collimated to create a focus where the radiation
from every source converges. At the focus, both the radiation intensity and its gradient
become very large. This makes it possible to deliver high radiation doses with minimal
damage to surrounding healthy tissue.
The PerfexionTM and IconTM systems enable two ways of tailoring the radiation dose
according to the shape and size of the target. First, the patient can be precisely moved
(robotically) in relation to the focus, effectively placing the focus in different isocenters.
Second, the radiation sources are arranged in eight, independently controlled, sectors. Each
sector can be in one of four different collimator states: the 4 mm, 8 mm or 16 mm or in the
beam-off state. For each isocenter position and collimator configuration (i.e. collimator size
for each sector), the irradiation time can be specified. This composition is often referred to
as a shot.
The large number of degrees of freedom allows sculpting of the dose distribution in un-
paralleled ways. At the same time, however, it is infeasible to explore them all by means of
manual planning. Thus, an inverse planning method is required to make the full potential
of LGK clinically accessible. Inverse planning methods only require the user to specify what
objectives to strive for, and then uses mathematical optimization to search for the best
possible treatment plan according to these objectives.
Inverse planning was introduced in Leksell GammaPlan R© 10, and has since then be-
come widely adopted. This inverse planner uses well-established metrics such as coverage,
selectivity and gradient index at a pre-determined isodose level, together with a beam-on
time (BOT) penalization. The optimization variables are the position of isocenters, colli-
mator configurations and irradiation times (beam weights more precisely). Unfortunately,
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the optimization problem is inherently difficult (non-convex). The difficulty arises from two
components: that the objectives use relative isodoses (instead of absolute doses) and that
the positions of the shots can change. Besides, the direct use of relative isodoses makes
it difficult to simultaneously manage multiple targets and to enforce criteria such as the
maximum dose to an organs at risk (OAR).
Researchers have proposed optimization approaches that use absolute doses and shots
that are allowed to move10–15. This typically results in a so-called mixed-integer problem,
which remains non-convex. In practice, this implies that there is a compromise between
computation time and the risk of ending up in a suboptimal solution. A consequence is that
it is difficult to explore what trade-offs are achievable—especially in complicated cases with
multiple conflicting objectives.
A remedy to most of these problems is to formulate a convex optimization problem.
Convexity is a highly desirable property that allows optimizations problems to be solved
reliably and efficiently16. One way to achieve convexity—which we also use—is to fix the
isocenter positions and perform sector-duration optimization17. This approach is inspired
by optimization formulations, in particular fluence map optimization, that are common in
intensity-modulated radiation therapy (IMRT)18,19. In sector-duration optimization, the
collimator configurations are not packaged into shots during the optimization, instead the
irradiation times of every collimator in every sector are treated independently during the
optimization. The irradiation times are converted into deliverable shots after a solution has
been found. Despite its promises, methods using sector-duration optimization has, so far,
lacked an efficient way of controlling BOTs20,21 and have been too computationally costly
for widespread clinical use15,17,22. This is about to change.
We present the first sector-duration optimization that uses linear programming, which
is possible thanks to a well-founded BOT penalization. Linear programming has a long
history in radiotherapy23–27, dating back at least to 196828. Many of the early approaches
constrained the doses to predetermined intervals and used the remaining freedom to max-
imize an objective function such as the mean26 or minimum29 dose in the target. But, in
practice, this upfront specification of dose constraints often lead to infeasible problems. This
motivated the use of elastic constraints30, where one instead minimizes the mean or maxi-
mum of the (weighted) constraint violations. Our formulation belongs to this category, but
with an additional term for BOT penalization.
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Linear programming has also been used in radiosurgery before, specifically in two-
phase approaches to inverse planning both for Gamma Knife radiosurgery31 and for robotic
radiosurgery32–34. There, the decision variables are the weights of (deliverable) beams/shots
that are generated in the first phase and optimized in the second. In Gamma Knife radio-
surgery, the sector-duration optimization has 24 times the number of decision variables of
the corresponding two-phase procedure. The equivalent of a sector-duration optimization for
a system with a multileaf collimator would include a decision variable for the left- and right
positions of every leaf, resulting in a roughly hundredfold increase of decision variables. In
this work, we present novel contributions that reduce the problem size of the sector-duration
optimization while preserving the flexibility it offers. In summary, our method
• Manages multiple targets;
• Explicitly handles OARs;
• Reproducibly finds the optimum given a fixed set of isocenter locations;
• Runs in well under a minute;
• Efficiently optimizes for short BOTs;
• Allows hard constraints;
• Allows the exploration of achievable trade-offs.
II. MATERIALS AND METHODS
To achieve convexity, we divide the planning into three distinct phases: isocenter place-
ment, optimization and sequencing. The isocenters chosen in the first phase remain fixed
throughout the rest of the planning. In the optimization phase, we formulate an optimiza-
tion problem where competing objectives are combined as a weighted sum. By changing
weights it is straightforward to explore achievable trade-offs. Possible objectives include
dose to target, sparing of OARs and a new—highly efficient—BOT penalization. During
the optimization, times for each sector and collimator are allowed to vary independently. In
the sequencing phase, these times are converted into deliverable shots.
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II.A. Isocenter placement
The first phase of the proposed inverse planner is to choose isocenter positions. These
remain fixed throughout the subsequent phases, defining the search space of the optimization.
The main objective of this phase is thus to provide enough freedom to find a high quality
plan; the only harm in including extra isocenter positions is that it will take longer time to
solve the optimization problem.
Although algorithms for automatic isocenter placement12,17,35–38 certainly have a role to
play, we do not consider them to be the main focus of this work. Consequently, to remove this
source of variability, we will reuse the isocenter positions from the corresponding (manual)
reference plan in all examples that follow.
II.B. Optimization
As we will describe below, a major difference between the inverse planner we propose
and previous approaches based on sector-duration optimization15,17,20–22 is that it uses linear
programming. Such optimization problems are well-behaved and well-studied16,39,40.
We recognize that there are multiple, possibly conflicting, objectives that are desirable.
However, our working assumption is that the exact priority among these should be provided
by the user. Consequently, we foresee that a number of options will be evaluated in the
course of optimizing the treatment plan. This indeed reflects how it works presently, but
the intention is that the proposed inverse planner will elucidate the achievable trade-offs.
Formally, suppose we have m cost functions, f = (f1(x), . . . , fm(x))
t, representing e.g. target
dose, dose to an OAR and a penalization of BOT. This can be conveniently rearranged into a
single cost function by forming a weighted sum, i.e. by scalar multiplication with the weights
w = (w1, . . . , wm)
t, where each weight quantifies the importance of the corresponding part
of the cost function. We will now describe how we have defined the different parts of the
optimization problem so that, taken together, it can be expressed as a linear programming
problem.
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II.B.1. Dose-based objectives
Given a fixed set of isocenter positions, our optimization variables are the irradiation
times tisc corresponding to every isocenter i, collimator state c and sector s. The dose D at
a position r is linear in terms of these irradiation times,
D(r, tisc) =
Niso∑
i=1
8∑
s=1
3∑
c=1
Φisc(r)tisc. (1)
Often, we are interested in the doses Dn given to a discrete set of voxels at positions rn,
where n = 1, . . . , N . Then, after appropriate rearrangements, we may evaluate the dose as
a matrix-vector multiplication: Dn = (Φt)n. Thus, the (N × 24Niso)-matrix Φ, which we
refer to as the dose rate kernel, maps irradiation times to doses.
In regions of interest, each voxel can be assigned dose-based objectives that reflect the
amount of underdosage or overdosage it receives. Typically, the regions of interest include
all targets, a volume of healthy tissue surrounding each target10,17 and clinically relevant
OARs. We express the dose-based objectives using one or several hinge functions,(
Dn − Dˆn
)
+
= max
(
Dn − Dˆn, 0
)
, (2)
where Dn is the dose in the voxel in question and Dˆn is a reference dose. This function, or its
square, is commonly used as a dose-based objective17,41. In principle, every voxel could have
a unique dose-based objective, which makes it possible to, for instance, perform full-fledged
dose painting by numbers42–44. By introducing auxiliary variables, piecewise linear convex
functions such as the hinge function above, can be recast as linear programming problems,
cf. appendix A.
II.B.2. Beam-on time penalization
To control the treatment time, we use a highly efficient penalization function which we
refer to as the idealized beam-on time (iBOT)20,21. It is defined as
Θ(t) =
Niso∑
i=1
max
s
3∑
c=1
tisc, (3)
where Niso is the number of isocenters; s and c, respectively, correspond to the 8 sectors and
3 collimators. We emphasize that iBOT is not an Lp-norm, nor does it promote sparsity—in
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fact, it is quite the opposite: it encourages the total BOT of each sector to be equally long,
which is advantageous since they can irradiate simultaneously. By introducing auxiliary
variables, the iBOT function can be expressed using linear programming45, cf. appendix A.
II.B.3. Constraints
In a linear programming problem it is possible to include hard constraints, i.e. condi-
tions that the solution must fulfill. Physics only dictates one such hard constraint, namely
that all times must be non-negative, t ≥ 0, and therefore this is the only hard constraint
that is strictly necessary—exempting the “artificial” constraints coming from the auxiliary
variables. One can, optionally, include hard constraints on doses in various regions.
II.B.4. Normal tissue sparing
We promote normal tissue sparing by encompassing the target within two non-overlapping
thick “shells” shaped according to the target surface. By penalizing high doses inside the
inner and outer shells we can control selectivity and gradient index (cf. section II.D),
respectively. These two shells may seem similar to the widely used concept of margins46,
but unlike margins—which have well-defined clinical meanings—our shells are merely used
to steer the optimization. We construct the inner and outer shells as geometric expansions,
defined via the Euclidean distance transform, of the target. The inner shell is expanded
from the target surface until its total volume is half that of the target volume. The outer
shell is expanded from the outer surface of the inner shell until its volume is twice that of
the target.
II.B.5. Illustrative example—primal formulation
We will base our exposition on a minimal, yet illustrative, example of the optimization
problem when there is a single target and an OAR where we want the limit the maximum
dose to at most DO. In this case, the cost function has four components that control the
target dose, selectivity, gradient index and BOT, respectively. We denote the prescription
dose to the target DT and the dose thresholds for selectivity and gradient index by DS and
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DG, respectively. We thus arrive at the optimization problem
minimize
t
wT
DTNT
NT∑
i=1
(DT − (ΦTt)i)+ + wS
DSNS
NS∑
i=1
((ΦSt)i −DS)+
+
wG
DGNG
NG∑
i=1
((ΦGt)i −DG)+ + wBOT
DT/ϕcal
Θ(t)
subject to ΦOt ≤ DO
t ≥ 0,
(4)
where ϕcal is the calibration dose rate, Nα is the number of voxels in the structures α ∈
{T, S, G, O} and the weights wα govern the relative importance of each term. Typically,
we let DS = DT to promote selectivity and DG = DT/2 to reduce the gradient index.
In appendix A, we give the explicit representation of the problem in Eq. (4) as a linear
programming problem on standard form.
The example given here can easily be extended in several ways. For instance, additional
structures could be incorporated as additional terms in the cost function, and homogeneous
(target) dose distributions could be promoted by including a hinge function that penalizes
overdosage.
II.B.6. Representative subsampling
The introduction of one auxiliary variable for every voxel in a relevant structure vastly
increases the size of the optimization problem. In realistic cases, there could be, say, 105
variables. Na¨ıvely solving the optimization problem thus becomes time-consuming at best,
but it could even be impossible due to memory limitations. Thus, it is essential to reduce
the size of the problem.
As a first step, we propose to use an approximation we refer to as representative sub-
sampling. Representative subsampling is based on the observation that the dose tends to
vary quite smoothly from one position to another. True enough, there are regions like the
penumbra region of the Gamma Knife (and flattening filter-free accelerators), that may ex-
hibit stronger variability than others, but for practical purposes it is redundant to take the
dose in every voxel into account during the optimization. We exploit this realization by
sampling only a representative fraction of the voxels in each structure that we use in the
optimization.
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Formally, we may understand this from the observation that most of the criteria involving
a structure Ω can be phrased as an integral
J =
∫
Ω
f (r,D(r, t))) dr , (5)
where f is a function that assigns a cost to the dose, D(r, t) = Φ(r)t, at position r. For
instance, a dose-based hinge functions, as in equation (2), corresponds to f(r,D(r, t)) =(
D(r, t)− Dˆ(r)
)
+
and a hard constraint on the maximum dose corresponds to
f(r,D(r, t)) =
0 if D(r, t) ≤ Dˆ(r),∞ otherwise. (6)
If we discretize the integral (5) uniformly (i.e. at the sampling points) we recover the
conventional expression
J ≈ V (Ω)
N
N∑
n=1
f(rn,Φ(rn)t), (7)
where V (·) is the volume operator. However, it is well-known that this scales poorly with
dimension—the number of samples required to reach a given precision increases exponen-
tially with the dimension. To mitigate this, researchers have proposed to subsample voxels
on a regular grid13 or to aggregate voxels into clusters47,48. Another option is to use a
stochastic gradient descent algorithm that resamples voxels at each iteration49, but stochas-
tic gradient descent is often ineffective on constrained problems, since every iteration requires
a projection onto the feasible set50.
Randomness is powerful, though. Instead of the deterministic sampling schemes men-
tioned above, we build upon the well-established efficiency of Monte Carlo integration to ap-
proximate Eq. (5) by sampling positions uniformly at random in the structure. In addition,
because we want to subsample also when using minimum and maximum dose constraints
in the target or maximum dose constraints in organs at risk, we include a separate term
corresponding to positions sampled at random on the tessellated surface of the volume.
II.B.7. Dualization
The introduction of auxiliary variables in the primal formulation increases the number of
variables—often severalfold. However, as can be appreciated from the explicit formulation
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in appendix A, the resulting matrix is highly structured; it could e.g. be decomposed as
the sum of a low-rank matrix and a sparse matrix. Exploiting this structure makes it
possible to reduce computation times drastically. We have found that dualization reduces
the computation time by a factor 5–20 depending on the features of the problem. Since
strong duality holds for linear programming problems, the primal and dual problems are
equivalent.
In appendix B we revisit our earlier example and give the explicit formulas for the cor-
responding dual problem. Importantly, however, the constraints introduced when rewriting
the hinge function using auxiliary variables become trivial thanks to the dualization. The
resulting size reduction leads to dramatic performance improvements when solving the dual
compared to the original, primal, problem. Moreover, the computational gain due to dual-
ization is entirely complementary to that of representative subsampling.
II.C. Sequencing algorithm for shot composition
For the Gamma Knife system to deliver the treatment composite shots are required,
i.e. collimator and sector configurations for each shot. The conversion from irradiation times
for each isocenter position tisc to such shots is referred to as sequencing. The sequencing
can be done in several different ways, and although we will not go into details here51, it is
worth noting that the result of the optimization will often lead to multiple shots in the same
isocenter position.
Fig. 1 The target volume (TV) and planning isodose volume (PIV)
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II.D. Evaluation
In Fig. 1, we define the target volume (TV) and the planning isodose volume (PIV),
which are used, together with the volume operator V (·), to define the common radiosurgery
metrics52:
Coverage: C = V (PIV ∩TV )
V (TV )
, (8)
Selectivity: S = V (PIV ∩TV )
V (PIV )
, (9)
Gradient index: GI =
V (PIVISO/2)
V (PIVISO)
. (10)
In words, coverage is the fraction of the target volume that receives at least as high dose
as prescribed, selectivity is the fraction of the planning isodose volume that encompasses
the target volume, and gradient index describes the dose fall-off by the ratio of the volume
that receives at least half the prescription dose to the planning isodose volume. In addition
to these metrics, plan quality is often evaluated based on the Paddick conformity index
(PCI)53, which is defined as:
Paddick conformity index: PCI = C · S. (11)
III. RESULTS
We have evaluated both the overall performance of the proposed inverse planner as well
as studied the novel components—the beam-on time penalization and the subsampling
scheme—in isolation. We begin by reporting on the beam-on time penalization and the
subsampling scheme. Then, we describe the overall performance on a set of 75 clinically
acceptable reference plans. Finally, we consider one case in more detail. For this case,
we illustrate the achievable trade-offs and show how to perform dose painting or create a
homogeneous dose distribution.
III.A. Beam-on time penalization
To show the efficiency of the iBOT penalization, we compare with replacing the term
Θ(t) in Eq. (4) with a simple summation over all times,
Θsimple(t) =
Niso∑
i=1
8∑
s=1
3∑
c=1
tisc, (12)
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which we refer to as simple BOT (sBOT). The rest of the objective function in Eq. (4) is left
unchanged. We make the comparison on three different cases: one small acoustic neuroma,
one medium sized acoustic neuroma and one irregular meningioma. By varying the weight
of the (selectivity promoting) inner shell against the BOT penalization while keeping the
other weights fixed, we obtain plans with different plan quality and BOTs. To get adequate
statistics, we ran 1000 optimizations for each case and choice of penalization. Plans with the
same Paddick index and gradient index to within ± 1 % were tallied and the average BOT
calculated for each bin. The bins were chosen to have Paddick and gradient indices within ±
5 % of the clinical plan. Table I summarizes the mean and standard deviation of the average
BOT with the iBOT penalization and the average BOT with the sBOT penalization, as well
as the mean and standard deviation of the ratios computed for each bin.
Table I BOT (min) at 3 Gy/min when using different penalization terms
Small acoustic neuroma Medium acoustic neuroma Irregular meningioma
iBOT 9.3 (2.6) 21.6 (1.5) 110.8 (3.1)
sBOT 16.8 (1.9) 75.2 (4.4) 303.2 (11.6)
iBOT/sBOT 0.55 (0.16) 0.29 (0.026) 0.37 (0.029)
Optimization times iBOT (s) 0.135 3.2 3.3
Optimization times sBOT (s) 0.125 3.4 3.5
Clearly, iBOT results in plans of equal quality but markedly shorter BOT than sBOT, in
particular for the two larger targets. The optimization times are practically equal. Figure 2
gives an overview of all the simulations for the small acoustic neuroma, for which the BOT
reduction was the smallest (but still almost a factor of 2). Figure 3 shows how the BOT,
Paddick index and gradient index depend on the iBOT weight. Even though the Paddick
index may appear independent of the iBOT in the small acoustic neuroma case (middle
left), recall from Eq. (11) that it is the product of coverage and selectivity. Separately
these are not constant as a function of BOT; a shorter BOT is obtained by increasing the
total dose rate, which for Gamma Knife is done by using larger collimators and more sectors
simultaneously. This smoothens the dose distribution so that coverage increases at the
expense of selectivity and gradient index.
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Fig. 2 Comparison of the two BOT penalization terms for the small acoustic neuroma case.
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Fig. 3 Dependence of BOT (top), Paddick index (middle) and gradient index (bottom) on the
iBOT penalization. The columns correspond to different cases: small acoustic neuroma (left),
medium acoustic neuroma (center) and irregular meningioma (right).
III.B. Subsampling
Since we subsample stochastically, the resulting plan metrics also become stochastic. We
do, however, want to choose the subsampling fractions such that the statistical fluctuations
remain reasonably small. Here, we require the standard deviation of both coverage and
selectivity to be below 1%. Furthermore, we want to ensure that our sampling strategy,
which samples both interior and surface points, performs at least comparably to sampling
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only in the interior.
We compare the two strategies on the three cases studied in Sec. III.A and an arteriove-
nous malformation case (AVM). Before sampling, the number of target voxels are 6119
(small acoustic neuroma), 12078 (medium acoustic neuroma), 27765 (meningioma) and
30326 (AVM). We adjust the voxel size for the interior point sampling so that the total
number of points in the target is the same for both sampling methods. We performed 100
runs for each of seven subsampling fractions. Figure 4 presents the resulting standard de-
viation of coverage and selectivity as a function of the percentage of the total number of
voxels, i.e. the voxels belonging to all structures in the problem. For each sampling method
we used a fixed weight setting ((wT, wS, wG, wBOT) = (1.0, 0.15, 0.15, 0.15) for our sampling
method and (wT, wS, wG, wBOT) = (1.0, 0.025, 0.025, 0.25) for interior sampling only) that
rendered clinically acceptable plans with metrics within 1% of each other. From Fig. 4, we
conclude that our sampling strategy performs comparably to the interior point sampling for
both coverage and selectivity. Also, we see that the standard deviation of both metrics is
below 1% when the subsampling fraction is at least 10%. The value of the metrics, and thus
the standard deviation, is computed on the original grid. For small sampling fractions, the
mean will deviate from the true value. However, for the sampling sizes we are interested in,
i.e. about 10%, this is typically not an issue.
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Fig. 4 The standard deviation of coverage and selectivity for the two sampling methods, interior
and surface (∗) and interior only (◦) for the small acoustic neuroma (red), the medium acoustic
neuroma (purple), the irregular meningioma (yellow) and the arteriovenous malformation (blue).
As illustrated in Fig. 5, subsampling shortens the optimization time. Evidently, the
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Fig. 5 The optimization time as a function of subsampling fraction for small acoustic neuroma
(red), the medium acoustic neuroma(purple), the irregular meningioma (yellow) and the arteriove-
nous malformation (blue).
dependence between the optimization time and the subsampling fraction is approximately
linear. In the cases considered above, asubsampling of 10% shortens the optimization time
by a factor 8–22 compared to using all initial sampling points.
III.C. Overall performance
We evaluate the overall performance by comparing the plan metrics for optimized plans
with manual forward plans for 75 clinical cases (the majority of Gamma Knife users still do
forward planning). The clinical cases are all single target cases: single metastases, acoustic
neuromas and meningiomas. The range in tumor size is 0.6–11.7 cm3 and the planning
dose range is 12–24 Gy. In 18 of these cases there are organs at risk (e.g. brainstem,
cochlea, optic nerves) so, to make a fair comparison, the maximum doses to the OARs
in the manual plans are used as hard constraints in the optimization. Furthermore, all
the manual plans have 98–100% coverage, so the weights were chosen to always satisfy this
criteria. To compare the manual and optimized plans, we have to find weight settings for each
optimized plan that give a similar trade-off between clinical objectives as the corresponding
manual plan. For simplicity, we employed the following strategy: first, we created a range
of plans with different characteristics by performing 101 optimizations for each case, with
randomly sampled weights for the inner ring and BOT penalization; then we selected, for
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each case, the optimized plan with the best gradient index among those with both higher
selectivity and shorter BOT than the corresponding manual plan. The resulting plan metrics
are shown in figure 6. In summary, for all of the 75 cases we could find optimized plans with
simultaneously higher selectivity and shorter BOT than the manual plans, and in 44 cases
these plans also had better gradient index than the manual plans. In other words, we found
plans that dominate the manual ones in almost 60% of the cases.
To solve the optimization problems, we used the open-source solver Glop54 with default
settings. The optimization times ranged from 2.3 to 26 s with a median time of 5.7 s on a
standard GammaPlan workstation (a HP Z640 with 32 Gb RAM and 12 cores running at
2.9 MHz). Figure 7 shows how the optimization time depends on the number of non-zero
elements in the constraint matrix B (cf. appendix B). We conclude that there is a linear
trend, but that the variation appears larger for small cases.
III.D. Detailed case study
As an example, we consider a large left-sided cavernous sinus meningioma, with a volume
of 16.2 cm3 and with three adjacent OARs: the chiasm, the left optic nerve and the left optic
tract. The prescription dose to target is 15 Gy, the dose in the inner shell encompassing
the target is penalized if the dose exceeds 15 Gy. In the outer shell we penalize doses
exceeding 7.5 Gy. The maximal allowed dose to all three OARs is 8 Gy, which is enforced by
hard constraints. In Tab. II, we present two optimized plans, one promoting selectivity and
one promoting short BOT, together with the clinical plan for comparison. Figure 8 shows
snapshots and dose-volume histograms from Leksell GammaPlan R© for the three different
plans. In the plan where short BOT is promoted, the BOT is almost halved at the expense
of a moderate decrease in selectivity compared to the second plan. However, we consider
both plans clinically acceptable.
III.D.1. Dose painting and homogeneous plans
The flexibility of the proposed inverse planner opens up new possibilities for treatment
planning. Here, we will exemplify both dose painting and how to create plans with a
16
(a)Selectivity for all the cases
(b)BOT for all the cases
(c)Gradient index for all the cases
Fig. 6 Metrics for the optimized plans compared to the forward plans. The cases are sorted by
the difference in gradient index.
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Fig. 7 Optimization time as a function of the number of non-zero elements in B for the 75 clinical
cases. The times shown are averages over the 101 runs made for each case.
Table II Plan metrics for the reference plan and two optimized plans
Reference plan Promoting selectivity Promoting BOT
Coverage 0.95 0.95 0.96
Selectivity 0.88 0.91 0.78
Gradient index 2.73 2.79 2.71
BOT (min) at 3 Gy/min 89 135 41
Max dose (Lt Optic nerve) 8.95 8.0 7.2
Max dose (Lt Optic tract) 7.3 8.0 7.2
Max dose (Chiasm) 7.3 8.0 7.2
Planning isodose 46 44 53
homogeneous dose distribution in the target.
Dose painting is achievable since both weights and prescription doses can be modified on
a voxel-by-voxel basis. To illustrate this, we introduce a hotspot, with a volume of 1.2 cm3,
in the center of the target. The dose prescribed to the hotspot is twice the dose prescribed
to the rest of the structure, i.e. 30 Gy. In the present example, we get a hotspot coverage
of 99 %.
It turns out that the iBOT term will in many cases favor fairly homogeneous plans. How-
ever, such plans can be further promoted by penalizing overdosage of the target. We thus
penalize doses exceeding 15/0.85 Gy to get a planning isodose of at least 85%, which is very
18
(a)Reference (b)Reference
(c)Promoting selectivity (d)Promoting selectivity
(e)Promoting BOT (f)Promoting BOT
Fig. 8 Snapshots and DVHs of the reference plan, the plan promoting selectivity and the plan
promoting BOT for the meningioma with adjacent OARs. The DVH for the target is in red and
the three OARs in magenta, light blue and pink.
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difficult using forward planning. In Tab. III, we present an example of a plan for the hotspot
case and one plan with a homogeneous dose distribution. Overall, we consider both plans
acceptable, although naturally the additional requirements result in some form of trade-off.
The hotspot case has similar plan quality but longer BOT than the clinically acceptable
reference plan presented in Tab. II. The homogeneous plan, on the other hand, trades off
selectivity and we need to loosen the hard constraint on dose to OARs to achieve homo-
geneity. In Fig. 9, we present snapshots of one plan with a homogeneous dose distribution
and one plan with a hotspot.
Table III One plan with a hotspot and one homogeneous plan
Hotspot Homogeneous plan
Coverage 0.97 0.95
Selectivity 0.85 0.87
Gradient index 2.9 2.8
BOT (min) at 3 Gy/min 136 152
Max dose target (Gy) 38.5 17.7
Max dose Lt Optic nerve (Gy) 8.0 8.0
Max dose Lt Optic tract (Gy) 8.0 8.0
Max dose Chiasm (Gy) 8.0 8.0
Planning isodose 40 85
IV. DISCUSSION
In this work, we have described a linear programming approach to Gamma Knife radio-
surgery based on the division of the planning into three distinct phases: isocenter placement,
optimization and sequencing. Our main focus has, however, been the optimization phase. We
have shown that even without changing the isocenter positions, our optimization approach
can find plans that dominate manual forward plans in almost 60% of the cases investigated.
Reusing the isocenter positions in this way clarifies the improvement that results directly
20
(a)Homogeneous plan
(b)Plan with hotspot
Fig. 9 Snapshots from one plan with homogeneous dose distribution and one with a hotspot
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from the optimization, but it is—of course—not how our approach would eventually be de-
ployed. A natural next step is thus to investigate methods for isocenter placement with an
emphasis on the interplay with subsequent phases.
Our optimization problem, with a cost function that is a weighted sum of multiple com-
peting objectives, is fundamentally a multi-criteria optimization problem. A useful concept
in multi-criteria optimization is that of the Pareto surface. Simply put, the Pareto surface
is the set of solutions in which you cannot improve one objective without impairing another.
This means one should never be satisfied with a solution that is not on the Pareto surface
(Pareto optimal) unless other considerations than explicitly expressed in the cost function
is taken into account. For example, our cost function only models gradient index and se-
lectivity indirectly, which means that we cannot guarantee Pareto optimality with respect
to these metrics. On the other hand, our results show that manual forward plans are, in
general, not Pareto optimal either and that the proposed inverse planner can often find plans
that dominate them.
For convex multi-criteria optimization problems, such as ours, every choice of weights
corresponds to a Pareto optimal solution. By specifying the weights before optimization, we
have treated this problem as a single-criteria optimization problem55. However, every Pareto
optimal point corresponds to the solution of the optimization problem for a set weights on
the unit simplex, i.e. such that w ≥ 0 and ∑ni=1 wi = 1. In other words, the formulation as
a weighted sum does not restrict the set of optimal plans that we can obtain. In practice,
our normalization is not ideal since the number of active points in each structure depends
on a number of factors, including the volume and the sampling strategy. Consequently the
exact weight settings are unlikely to generalize from one case to another even though they
may be quite similar. We thus expect that the planner will have to adjust the weights a few
times before arriving at a satisfactory solution.
Although not explored here, we anticipate that further computational gains are attain-
able by cleverly manipulating the dose rate matrix Φ(r) and adapting the matrix algebra
accordingly56–58. We also expect that tuning or replacing the solver, or both, could shorten
the optimization times further59.
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V. CONCLUSIONS
We present the first sector-duration optimization that uses linear programming. It uses a
beam-on time (BOT) penalization tailored to the Gamma Knife, which reduces the BOT by
a factor of 2–3 compared to the na¨ıve alternative. In addition to using linear programming,
we describe two techniques that reduce the problem size and thus further reduce the solu-
tion time: dualization and representative subsampling. Dualization leads to an equivalent
problem that can be solved 5–20 times faster than the primal one. With representative
subsampling we refer to a stochastic sampling of positions, both in the interior and on
the surface of relevant structures, to use in the optimization. We show that using 10% of
the original number of voxels is enough to generate plans for which the statistical fluctua-
tions in coverage and selectivity are below 1% while resulting in time-savings comparable to
dualization.
The importance of different objectives, such as coverage, selectivity or beam-on time
(BOT), are controlled by adjusting the weights of the corresponding terms in the cost func-
tion. In a comparison with 75 clinical plans we show that in 44 of these we can find plans
that simultaneously have better selectivity, BOT and gradient index (with coverage close to
100% in all cases) than the forward plans.
Treatment planning for Gamma Knife has always been highly interactive. Thanks to
the combination of techniques to reduce the computational cost that we have presented, it
becomes possible to fit sector-duration optimization—with all its benefits—into the clinical
workflow. This is our main contribution.
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Appendix A: Explicit formulation of the primal problem
Any linear programming problem can be written in the form
minimize
x
wtx
subject to Ax = b
x ≥ 0,
(A1)
where x ∈ Rn are the optimization variables and w, b and A ∈ Rp×n define the objective
and constraint functions of the problem.
We introduce auxiliary variables to rewrite the hinge and iBOT functions using linear
programming: if y+, y− ≥ 0 and D−Dˆ = (y+−y−), then y+ ≥ (D−Dˆ)+ and y− ≥ (Dˆ−D)+;
if τi ≥
∑3
c=1 tisc for s = 1, . . . , 8, then τi ≥ maxs
∑3
c=1 tisc. We may then express the primal
optimization problem (4) in standard form by making the following identifications:
A =

ΦT −I I 0 0 0 0 0 0 0
ΦS 0 0 −I I 0 0 0 0 0
ΦG 0 0 0 0 −I I 0 0 0
ΦO 0 0 0 0 0 0 I 0 0
C 0 0 0 0 0 0 0 I −T

,
xt =
(
t, y+T , y
−
T , y
+
S , y
−
S , y
+
G, y
−
G, p, q, τ
)
,
wt =
(
0, 0,
wT
NTDT
,
wS
NSDS
, 0,
wG
NGDG
, 0, 0, 0,
wBOT
DT/ϕcal
)
,
bt = (DT, DS, DG, DO, 0) ,
(A2)
where
C =

1 1 1 0 0 0 . . . 0 0 0
0 0 0 1 1 1 . . . 0 0 0
...
...
...
...
...
...
. . .
...
...
...
0 0 0 0 0 0 . . . 1 1 1
 = INiso ⊗ I8 ⊗ (1, 1, 1) ∈ R
8Niso×24Niso , (A3)
T = INiso ⊗ 18×1 ∈ R8Niso×Niso , (A4)
and ⊗ denotes the Kronecker product.
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Appendix B: Explicit formulation of the dual problem
Most modern linear programming solvers begin with a presolve step that intends to reduce
the problem size60. However, for completeness and because we haven’t encountered a solver
that automatically detects the benefit of dualizing our problem, we will here carry out the
dualization explicitly.
The dual problem corresponding to a linear programming problem on standard form,
equation (A1), is16,39,40
minimize
ν
btν
subject to Atν + w ≥ 0,
(B1)
where the dual variable ν is the Lagrange multiplier for the linear constraints of the primal
problem. By eliminating redundant variables and grouping constraints, our problem can be
stated as
minimize
ν˜
ρtν˜
subject to Btν˜ ≤ σ,
` ≤ ν˜ ≤ µ ,
(B2)
where we have introduced the following rescaled entities
ν˜ = (
νT
DT
,
νS
DS
,
νG
DG
,
νO
DO
,
νiso
DT/ϕcal
) ,
ϕT =
φT
DT
, ϕS =
φS
DS
, ϕG =
φG
DG
, ϕO =
φO
DO
, Cs =
C
DT/ϕcal
.
(B3)
We may then express the dual optimization problem corresponding to equation (A2) by
making the following identifications
ρt = (−1, 1, 1, 1, 0) ,
Bt =
ϕtT −ϕtS −ϕtG −ϕtO −Cts
0 0 0 0 T t
 ,
σt = (0, wBOT) ,
` = (0, 0, 0, 0, 0) ,
µ =
(
wT
NT
,
wS
NS
,
wG
NG
,∞,∞
)
.
(B4)
The number of non-zero elements in B is (24(NT +NS +NG +NO) + 32)Niso.
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